About Volta
Non Dispersed Electrocardiograms
Dispersed Electrocardiograms
1
dispersion location
Multipolar electrogram abnormality associated with the perpetuation of atrial fibrillation. Red: highly dispersed electrograms, Orange: dispersed electrograms, Blue: non-dispersed electrograms.
2
mapping catheter
Steerable, multipolar electrode catheter. Allows for the recording of the local electrical activity.
3
reference cycle length
Atrial cycle length estimated from recordings obtained with the coronary sinus catheter.
4
mapping cycle length
Local cycle length estimated from real-time recordings obtained with the mapping catheter.
1
dispersion location
Multipolar electrogram abnormality associated with the perpetuation of atrial fibrillation. Red: highly dispersed electrograms, Orange: dispersed electrograms, Blue: non-dispersed electrograms.
2
mapping catheter
Steerable, multipolar electrode catheter. Allows for the recording of the local electrical activity.
3
reference cycle length
Atrial cycle length estimated from recordings obtained with the coronary sinus catheter.
4
mapping cycle length
Local cycle length estimated from real-time recordings obtained with the mapping catheter.
Compliance
Patient privacy: All data collected is anonymized or pseudonymized in compliance with Data Protection regulations. Notably, data undergoes a state-of-the-art encryption (dual process, dual keys). Our policy meets the highest standards of data protection.
CE marked & FDA cleared: Volta’s VX1 software solution is the first AI-based solution in the interventional cardiology space to have obtained FDA clearance and CE marking.
Technology
Real time analysis: VX1 provides state-of-the-art analysis in real-time, ensuring optimal usability.
Precision: its integration allows for high density mapping in both atria.
Intellectual Property: Volta’s technology is protected internationally with multiple patents.
Data Driven: VX1 algorithm has been trained on large, carefully curated databases. Our goal is to mimic the expertise of trained physicians and reduce inter-operator variability in identifying specific abnormal electrograms.
Compatibility
Most multipolar mapping catheters
Two EP recording systems
Most 3D navigation systems
VX1. vs. Trained Expert Cardiac Electrophysiologists
Conclusions
SOURCE: HRS 2020 Imagineer Tech Showcase.
-
The clinical significance of utilizing the VX1 software to help identify areas with intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion
for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations.
Our team
Management
Team
El Makki Voundy
Full-Stack Developer
Fabienne Pouplier
DPO
Mohsen Shah
US Business Development Manager
Daniel Guerrero
US Clinical Operation Manager
Didier Villevalois
Full-Stack Developer
Philippe Tartaise
Lead Developer
Julien Seitz
President, co-founder
+
Julien Seitz
President, co-founder
Julien is the acting Chief of the cardiac electrophysiology section at Saint Joseph Hospital (Marseille, France).
St-Joseph hospital is one of the three highest-volume ablation center in the country. This gave him many opportunities to think deep about what interventional cardiologists need most. Julien is well-known for his contributions to the field of electrogram-based ablation. He has published plenty of manuscripts in high-impact cardiology journals. He is a regular guest speaker, chairman at major conferences.
Since he started as an interventional cardiologist, Julien has been obsessed with making accessible any complex ablation approach to large numbers of colleague physicians. He started with conceptualizing multipolar-electrogram visual interpretation into a series of simple steps.
Since Volta was created, he used his in-depth experience to help design AI algorithms that provide simple but powerful cues to cardiologists.
Théophile Mohr Durdez
CEO, co-founder
+
Théophile Mohr Durdez
CEO, co-founder
Théophile grew up in France, Germany and Austria. Since his young age, he wanted to help his fellow humans with technology. Latter on, he studied at Ecole polytechnique (Paris), where he fell in love with Statistics, Machine and Deep Learning. There, he obtained a double degree with the Business School HEC (Paris).
His first accomplishment was to create a wheelchair controlled via eye-tracking for SLA disabled people. He then helped in solving complex geophysics with the use of differential equations.
In 2016, he co-founded Volta, where he was the passionate architect and inventor of Volta’s algorithms. In 2017, Théophile received the Research Award from Ecole polytechnique for the algorithms that he developed at Volta.
Théophile is hiring and leading a team of top-talents to drive Volta towards success by making a difference for operators and patients.
Clément Bars
VP, co-founder
+
Clément Bars
VP, co-founder
Clément has devoted his career to refining his understanding of procedural work flows in the field of cardiovascular electrophysiology.
Clement has become a well-known expert at simplifying work flows, specifically as they pertain to atrial fibrillation catheter ablation. His many contributions to the field of ablation could be summarized as “Do what you understand well, but keep it simple”.
He is regularly invited as a guest speaker or as a proctor in major hospitals in Europe, USA and Asia.
At Volta, he oversees the clinical evaluation of Volta’s algorithms. With more than 40 cardiac electrophysiologists visiting us last year alone, Clément has formed a large network of interventional cardiologists that cannot wait to try Volta’s algorithms.
Sabrina Siame
Clinical Research Assistant
Aman
Business Analyst
Loren Siry
HR Manager
Dinara Veshchezerova
Data Scientist
Mélanie Reist
Field Technical Engineer
Meryem Serdi
Field Technical Engineer
Maxime Basset
Field Technical Engineer
Paola Milpied
VP Clinical & Regulatory Affairs
+
Paola Milpied
VP Clinical & Regulatory Affairs
Paola is a former engineer and data scientist who holds a PhD in signal processing and machine learning applied to Cardiology. She has 13+ years of experience in medical device companies in France and in the US where she held several roles in clinical research and regulatory affairs in the cardiovascular field.
At Volta, Paola leads the clinical, quality and regulatory affairs department with an ambitious clinical program as well as major regulatory challenges.
Yoann Dutil
QMS Compliance Manager
Audrey Balzano
Executive Assistant
Quentin Taburet
Data Scientist
Thomas Boudou
Data Scientist
Camille Schmisser
Clinical & Regulatory Affairs Specialist
Idriss Lopes Sanches
Developer
Aurélien Rosiau
Full-Stack Developer
Vianney Guesdon-Vennerie
Front-End Developer
Denis Hansjacob
COO
+
Denis Hansjacob
COO
After more than 30 years as a high-level executive in the Biomedical Device Industry, Denis decided to join Volta to be part of the next wave of technology designed for the operating room.
Denis has been Managing Director of St. Jude Medical France and Vice-President for Northern Europe, where he led commercial operations. He has a unique understanding of marketing, sales and reimbursement mechanisms. Denis is helping Volta’s products spread quickly in Europe and the USA.
Also, Denis is shaping the future of biomedical devices revenue model. Denis is the proponent that AI is the best solution to cure more patients from AF in the best cost efficient way.
Anton Vorobev
CFO
+
Anton Vorobev
CFO
Anton is an HEC Paris graduate with experience in financial modeling, startup funding and business strategy.
He is co-founder and founder of several start-ups and he led regional operations for a Dutch IT company.
Anton’s business background allows for accelerating Volta’s international growth and helps Volta Medical with refining its financial strategy.
Jérome Kalifa
Chairman, CMO, co-founder
+
Jérome Kalifa
Chairman, CMO, co-founder
Both basic scientist and clinical electrophysiologist, Jérôme is based in the USA and currently Faculty at Brown University, Rhode Island, USA.
Jérôme dedicated about two decades to translational and clinical research in cardiac electrophysiology.
He is a seasoned speaker, chairman and reviewer for cardiology journals and conferences. His research effort has focused on understanding atrial fibrillation mechanisms as they pertain to cardiac interventions.
His background in cardiac mapping, imaging, database management and catheter technologies helped us design Volta’s algorithms.
Jérôme’s knowledge of the US clinical landscape is helping Volta address the needs of US users.
Anthony Appetiti
Head of Sales EU
Rebecca Sircoulomb
Head of product
Investors & Partners
Press releases
First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis
First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis
Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in patients undergoing ablation treatment for persistent, drug-resistant atrial fibrillation (AF), a common heart condition.
New York-Presbyterian Queens, Northwell Health’s Lenox Hill Hospital, New York City, and Ascension St. Vincent’s Riverside, Jacksonville, Fla. are the first U.S. medical centers to use Volta’s VX1 product. All three are participating in an international, randomized, controlled clinical trial to evaluate the outcomes of VX1-guided ablation versus standard ablation. They are actively recruiting patients for the trials.
Marseille, France and Providence, Rhode Island, USA December 21, 2021 – Volta Medical, a pioneering health tech company developing artificial intelligence (AI)-based software solutions to treat cardiac arrythmias, today announced the introduction of its leading-edge product, VX1, at three leading U.S. hospitals. New York Presbyterian Queens, Northwell Health’s Lenox Hill Hospital both in New York City, and Ascension St. Vincent’s Riverside, Jacksonville, Fla., are the first U.S. hospitals to implement VX1, which is designed to improve outcomes for patients undergoing atrial fibrillation (AF) ablation procedures.
All three hospitals also are recruiting AF ablation patients to participate in an international, randomized controlled clinical trial to evaluate the outcomes of VX1-guided ablation versus standard ablation. VX1 is cleared as a medical device by the U.S. Food and Drug Administration and CE-certified by the European Union.
VX1 is the first commercially available AI software to help clinicians combat high failure rates in the use of ablation for treating persistent, drug-resistant AF. AF, characterized by an irregular and chaotic heartbeat (cardiac arrythmia), can lead to more serious health issues such as heart failure and stroke. During AF ablation, a specialized cardiologist known as an electrophysiologist inserts catheters through the blood vessels into the heart to burn or freeze that tissue that is causing abnormal electrical signals in the upper chamber, or atrium. The procedure creates scarring that restores a normal heartbeat.
The VX1 system analyzes electrical signals measured during the procedure and identifies abnormalities in real-time. VX1 is versatile and can be installed in most operating rooms and is compatible with the main multipolar catheters and mapping systems.
“We are excited by the potential this approach has to help our patients who are living with persistent, drug-resistant AF,” says Seth Goldbarg, MD, Director of Cardiac Electrophysiology at New York-Presbyterian Queens and assistant professor of clinical medicine at Weill Cornell Medicine. “The VX1 system may help us tailor our procedures for each patient by more precisely pinpointing optimal ablation locations in real time.”
“To date, electrophysiologists have relied on their own experience and on simple analysis tools to make decisions about ablation locations as opposed to using robust measurable electrical abnormalities,” said Théophile Mohr Durdez, CEO and Co-Founder of Volta Medical. “To date, we have supported approximately 500 procedures with our AI-based analysis and the feedback has been excellent. We are very confident that this approach can help revolutionize the field and prove to significantly improve patient outcomes.”
Toward that end, Volta Medical has initiated the TAILORED-AF trial, the first randomized controlled clinical trial to evaluate VX1-guided ablation compared to conventional anatomical ablation approaches. The international, multi-center trial will involve 25 sites and 342 patients and is expected to report results in 2024.
“Treating the large number of patients with severe forms of drug-resistant, persistent AF remains an ongoing challenge for clinicians because current therapeutic strategies cannot offer predictable efficacy,” said Stavros Mountantonakis, MD, Director of Cardiac Electrophysiology at Lenox Hill Hospital, part of Northwell Health. “We’re finding VX1 to be a valuable tool in our ablation procedures, and we’re hopeful that the TAILORED-AF trial will validate its use as a game-changing innovation in ensuring improved, long-term results for these patients.”
“Our patients with drug-resistant, persistent AF face many ongoing challenges, and we’re pleased to be offering the VX1 system as a promising new treatment strategy for their ablation procedures,” said Saumil R. Oza, MD, a cardiologist with Ascension St. Vincent’s Riverside in Jacksonville, Fla. “Current ablation techniques cannot offer predictable efficacy, which is why the VX1 system holds so much promise. Because it enables us to precisely pinpoint optimal ablation locations for each patient, we are confident that it will lead to better treatment outcomes.”
Dr. Seth Goldbarg receives compensation in his role on the scientific advisory board for Volta Medical and the steering committee for the Tailored AF Trial. Dr. Goldbarg also owns shares in Volta Medical.
About Atrial Fibrillation (AF)
An estimated 6.1 million people in the United States have AF with projections to reach nearly 12.1 million in 2030.4,5 Worldwide, it affects more than 33 million people.1 Symptoms include palpitations, lightheadedness and shortness of breath. In some patients, AF can lead to heart failure. AF is not only an extremely costly public health issue but also a major risk factor for stroke, posing a 4-to-5 times greater risk than for the general population.6 AF is commonly treated with medication that regulates or slows the heart rate.2 For patients who cannot tolerate or are resistant to anti-arrhythmic drug therapy, ablation is the current standard of care.2 Ablation uses heat or cold energy to create tiny scars in the heart to block abnormal electrical signals and restore a normal heartbeat. However, the efficacy of this approach depends largely on the experience and intuition of the electrophysiologist. With 50% of persistent AF patients requiring repeat treatments,7 the need for more precise therapies is significant.
About the TAILORED-AF trial
TAILORED-AF is an international, multicenter trial designed to determine if a tailored VX1 AI software-guided ablation strategy targeting areas of spatiotemporal dispersion in combination with pulmonary vein isolation (PVI) is superior to a conventional anatomical ablation strategy targeting PVI alone for the treatment of persistent AF. The primary endpoint of the study is the absence of documented AF episodes > 30 seconds, with or without anti-arrhythmic drugs (AADs), 12 months after a single index ablation procedure. Secondary endpoints include absence of AF and/or atrial tachycardia (AT) episodes after a 12-month period, following one or more procedures, as well as safety. Volta Medical expects results from the TAILORED-AF trial in 2024.
For more information about participating in the TAILORED-AF trial, contact Dan Guerrero daniel.guerrero@volta-medical.com.
About Volta Medical
Volta Medical is a health tech company developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to significantly improve cardiac arrythmia management by developing state-of-the-art, data-driven medical devices based on large databases of procedural data with the highest standards of data protection. Founded by three physicians and a data scientist in 2016 in Marseille, France, Volta’s first product, VX1, assists cardiologists in the real-time identification of specific abnormal electrograms, known as dispersed electrograms. For more information, visit the company’s website at www.volta-medical.com.
Media Contacts United States
Glenn Silver
Lazar-FINN Partners
glenn.silver@finnpartners.com
(973) 818-8198
Volta Medical raises 23 million Euros to revolutionize persistent AF ablation
Volta Medical raises 23 million Euros to revolutionize persistent AF ablation
Marseille, 7 January 2021 – Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence (AI) algorithms to treat cardiac arrythmias, today announced that it has successfully raised 23 million Euros. The financing round was led by Gilde Healthcare with participation of existing shareholder Pasteur Mutualité. The new capital will allow the company to establish its revolutionary FDA-cleared and CE marked VX1 AI software solution as a new standard of care, pursue further R&D activities and start to roll out commercial activities across the US and Europe. Recruitment for TAILORED-AF, an international multicenter trial has already started. Volta Medical will be welcoming two new Board members. Janke Dittmer, General Partner at Gilde Healthcare, has been nominated as a board member and former medical device industry top executive, Denis Gestin, as an independent board member.
After developing the first commercially available AI software to help electrophysiologists improve management of cardiac arrythmias, Volta Medical is now preparing to transform the way ablation procedures will take place in the future. Theophile Mohr-Durdez, CEO and co-founder of Volta Medical mentioned: “We are excited to be able to complete our highly ambitious medical program with the start of TAILORED-AF, a new randomized controlled trial (RCT). This trial aims to demonstrate how our AI software can help physicians optimize both efficacy and efficiency when performing complex procedures to treat heart rhythm disturbances.” Atrial fibrillation (AF) currently affects over 30 million patients worldwide. This underlines the importance of the TAILORED-AF trial which is likely to result in a breakthrough approach for tackling one of the world’s greatest public health challenges in a more consistent and reproducible manner. According to Gilde Healthcare’s Janke Dittmer, “We are excited to support Volta’s team in bringing a unique solution to address one of the biggest unmet needs in the large and fast-growing electrophysiology market”.
About atrial fibrillation (AF)
AF can be considered an “electrical storm” in the atria in which all synchronized activities have disappeared, and the necessary coordination of the contraction stops. This can lead to a number of symptoms including palpitations, shortness of breath, and in some patients, heart failure. AF is also a major risk factor for stroke, as stagnant blood in the atrium during AF may lead the formation of a clot, that can migrate to the brain. AF increases the likelihood of stroke by four to five times and AFib-induced strokes that are generally associated with more severe damage.
AF is an extremely costly public health problem. It affected approximately 6 million patients in the US in 2019 and 11 million patients in Europe in 2018 and prevalence is estimated to double by 2060. In Europe 120,000-215,000 new cases are projected to occur each year reaching a total AF patient population prevalence of 14-17 million by 2030. Evidence suggests a higher prevalence of AF in patients with hypertension, heart failure, coronary heart disease, obesity, diabetes. In addition, recent studies show that 20-30% of patients with ischemic stroke have had AF before, during or after the initial event.
The TAILORED-AF trial
TAILORED-AF is an international, multicenter trial designed to compare the VX1 AI software ablation strategy with currently used conventional anatomical ablation approaches. According to Dr Tom De Potter, Head of Electrophysiology, OLV Hospital, Aalst, Belgium and one of the TAILORED-AF trial investigators, “treatment of the more severe forms of drug-resistant persistent AF remains a major challenge in our field, both due to the large number of patients affected and lack of therapeutic strategies that can offer predictable efficacy. Thanks to the software’s ability to identify signals that are relevant, from those that are less relevant, one of its greatest and most unique benefits is to allow for a more easily reproducible approach to ablation.” The results of the Ev-AIAFIB proof of concept study carried out with VX1 in 8 different centers will soon be published. They will provide data on why and how this new approach has the potential to provide electrophysiologists with a guidance tool that will optimize treatment of patients with AF in a lasting manner.
Conventional ablation methods, while useful for treating patients, who cannot tolerate or who are resistant to anti-arrhythmic drug therapy, have so far been less precise than desired. Their results, even if significant in certain cases, remain sub-optimal. Localization and ablation of drivers perpetuating AF have been at the forefront of cardiovascular disease research but have not led to any radical changes to-date. Volta’s system is intuitive, user-friendly and shows promise to potentially reduce inter-operator variability in the analysis of procedural data without lengthening either the diagnostic or therapeutic procedures. “We are eager to help new centers access and use our revolutionary tool during ablation procedures. This cutting-edge medical innovation enhances the efficiency and precision of the practitioners who are analyzing real-time data in the operating room. Its robustness will help physicians adopt a more efficient workflow and take the right decisions” – claimed physician co-founder, Jerome Kalifa.
About Volta Medical
Founded by three physicians and a data scientist in 2016 in Marseille, Volta Medical is a HealthTech company developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to drastically improve cardiac arrythmia management by developing state-of-the-art, data-driven medical devices based on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists for the real-time identification of specific abnormal electrograms, known as dispersed electrograms.
For more information, visit the company’s website at www.volta-medical.com.
About the VX1 AI software
VX1 consists of a highly innovative AI algorithm that is compatible with most readily available multipolar catheters and technologies currently used in operating rooms or electrophysiology labs. The VX1 software analyzes the patient’s electrograms in real-time to identify specific electrograms known as dispersed electrograms. It also provides a cycle length estimation from electrograms recorded with the mapping and the coronary sinus catheters.
The clinical significance of utilizing the VX1 software to help identify areas with intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations.
VX1 is a medical device which is FDA cleared and has a CE mark.
About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €1.4 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in fast growing companies active in digital health, MedTech and therapeutics. The venture & growth companies are based in Europe and North America. For more information, visit the company’s website at www.gildehealthcare.com.
Media Contacts
BCW agency
Linda Pavy – Tel: +33 (0)6 07 59 43 95 – Email: linda.pavy@bcw-global.com
Maëly Daviles – Tel: +33 (0)6 13 20 51 02 – Email: maely.daviles@bcw-global.com
Pauline Coudert – Tel +33 (0)6 88 38 46 58 – Email: pauline.coudert@bcw
References
1.https://globalheartjournal.com/articles/abstract/10.1016/j.gheart.2014.01.004/
2.https://www.ahajournals.org/doi/10.1161/strokeaha.115.012004
3.https://pubmed.ncbi.nlm.nih.gov/14966048/
4.Marco V. Perez, M.D., Kenneth W. Mahaffey, M.D., Haley Hedlin, Ph.D., John S. Rumsfeld, M.D., Ph.D., Ariadna Garcia, M.S., Todd Ferris, M.D., Vidhya Balasubramanian, M.S., Andrea M. Russo, M.D., Amol Rajmane, M.D., Lauren Cheung, M.D., Grace Hung, M.S., Justin Lee, M.P.H., et al., Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation, N Engl J Med 2019; 381:1909-1917
5.https://www.jnjmedicaldevices.com/sites/default/files/2020-07/Burden%20of%20Disease%20Full%20report.pdf
6.Krijthe, Bouwe P., et al. “Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.” European heart journal 34.35 (2013): 2746-2751.
7.2017 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016;37:2893–2962.doi:10.1093/eurheartj/ehw210
8.Authors/Task Force Members:, et al. “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.” EP Europace 18.11 (2016): 1609-1678.
Volta Medical’s VX1 AI software for use in atrial fibrillation mapping now FDA cleared
Volta Medical’s VX1 AI software for use in atrial fibrillation mapping now FDA cleared
Marseille, December 10, 2020 –Volta Medical, a pioneering French-based HealthTech startup is pleased to announce that it has obtained FDA clearance for its revolutionary VX1 AI (artificial intelligence) software. This is the first FDA clearance for an AI based tool in interventional cardiac electrophysiology. VX1 is a machine and deep learning-based algorithm designed to assist operators in the real-time manual annotation of 3D anatomical and electrical maps of the human atria during atrial fibrillation (AFib) or atrial tachycardia. These annotations help physicians locate heart regions harboring a specific electrogram abnormality, known as spatiotemporal dispersion. This innovative detection and patient-specific localization of abnormal regions may eventually help physicians better decide where they need to intervene to either burn (radiofrequency) or freeze (cryotherapy) faulty electrical pathways.
According to Seth H. Goldbarg, MD, FACC, FHRS, Director of Cardiac Electrophysiology, New York Presbyterian/Queens, Assistant Professor, Weill Cornell Medical College, Flushing, NY, USA, “AFib represents a major challenge in cardiology due to the complexities associated with identification, localization and treatment of the pathological zones that cause and perpetuate this abnormal heart rhythm. The current standard of care does not provide us with a uniform, easy to follow and predictable approach to identify these regions. This has led to heterogenous approaches to treating these patients, with very mixed and often disappointing results. We are excited to be part of the further studies taking place with this AI software, as the VOLTA system may provide a major step forward in the effective approach to ablation of persistent AFib.”
Conventional ablation methods, while useful for treating patients, who cannot tolerate or who are resistant to anti-arrhythmic drug therapy, have so far been less precise in persistent AFib patients than desired. Their results, even if significant in certain cases, remain sub-optimal. Localization and ablation of drivers perpetuating AFib has been at the forefront of cardiovascular disease research but has not led to any radical changes to-date. The Volta mapping system is intuitive, user-friendly and shows promise to potentially reduce inter-operator variability in the analysis of procedural data without lengthening either the diagnostic or therapeutic procedures.
The VX1 system holds enormous promise for offering an easier, faster, more accurate and reliable way to identify zones of interest in patients who suffer from chaotic heart muscle contractions. Developed jointly by top experts in the fields of electrophysiology and digital technologies, VX1 is simple to use. It bears the potential to provide a permanent solution to a chronic health burden with a one-time breakthrough procedure and has the potential to become the gold standard AI solution, for efficient and affordable cardiac ablation procedures. For Jérôme Kalifa, MD and cofounder of Volta Medical “our ultimate goal is to offer an alternative to a lifetime of medication that can have problematic side effects in some patients, while bringing a better quality of life to those who suffer from bothersome daily disease symptoms. This is what is generating increasing enthusiasm around the potential of our solution. The recently obtained FDA clearance is an important milestone for our company and ultimately for patients who suffer from difficult to treat forms of AFib”.
About Volta Medical
Founded by three physicians and a data scientist in 2016 in Marseille, Volta Medical is a HealthTech company developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to drastically improve cardiac arrythmia management by developing state-of-the-art, data-driven medical devices trained on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists for the real-time identification of specific abnormal electrograms, known as dispersed electrograms.
For more information, visit the company’s website at www.volta-medical.com.
About the VX1 AI software
VX1 consists of a highly innovative AI algorithm that is compatible with most readily available multipolar catheters and technologies currently used in operating rooms or electrophysiology labs. The VX1 software analyzes the patient’s electrograms in real-time to identify specific electrograms known as dispersed electrograms. It also provides a cycle length estimation from electrograms recorded with the mapping and the coronary sinus catheters. The clinical significance of utilizing the VX1 software to help identify areas with intra-cardiac atrial electrograms exhibiting spatiotemporal dispersion for catheter ablation of atrial arrhythmias, such as atrial fibrillation, has not been established by clinical investigations. VX1 is a medical device which is FDA cleared and has a CE mark.
About atrial fibrillation (AFib or AF)
AFib can be considered an “electrical storm” in the atria in which all synchronized activities have disappeared, and the necessary coordination of the contraction stops. This can lead to a number of symptoms including palpitations, shortness of breath, and in some patients, heart failure. AFib is also a major risk factor for stroke, as stagnant blood in the atrium during AFib may lead to the formation of a clot, that can migrate to the brain. This is why AFib is such an important risk factor for heart failure and stroke and a major reason for loss of quality life.
AFib is expected to reach 12.1 million patients in the US by 2030. Prevalence of arrhythmias increases with age and total annual costs for treatment of AFib in the US were estimated already in 2001 at US$6.65 billion. Evidence suggests a higher prevalence of AFib in patients with hypertension, heart failure, coronary heart disease, obesity and diabetes. In addition, recent studies show that 20-30% of patients with ischemic stroke have had AFib before, during or after the initial event. AFib increases the likelihood of stroke by four to five times while AFib-induced strokes are generally associated with more severe damage.
Media Contacts
BCW agency
Linda Pavy – Tel: +33 (0)6 07 59 43 95 – Email: linda.pavy@bcw-global.com
Maëly Daviles – Tel: +33 (0)6 13 20 51 02 – Email: maely.daviles@bcw-global.com
Pauline Coudert – Tel +33 (0)6 88 38 46 58 – Email: pauline.coudert@bcw
References
1.https://www.cdc.gov/heartdisease/atrial_fibrillation.htm
2.https://www.uscjournal.com/articles/epidemiology-economic-burden-af
3.Authors/Task Force Members:, et al. “2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.” EP Europace 18.11 (2016): 1609-1678.
4.https://www.ahajournals.org/doi/10.1161/strokeaha.115.012004
Looking for new talents
Volta Medical brings together a team of top-talent dedicated to make a difference in the field of interventional cardiac electrophysiology.
Volta’s collaborators come from multiple countries and continents.
Our headquarters are located in Marseille. Marseille is in the South of France, on the Mediterranean sea. This creates a unique atmosphere, particularly prone to creativity and collaboration.
At Volta, we are convinced that everyone of us may contribute to improving the lives of patients with cardiac arrhythmias. This is what drives us to come to work every single day. Many of us also enjoy the natural scene and conviviality in Marseille. You may find us celebrating milestones nearby (or on!) the Mediterranean sea.
If you are inspired, feel free to reach out! We would love to review your application.
Développeur / Concepteur H/F
Marseille, France
Développeur / Concepteur H/F
Qui sommes-nous ?
Volta Médical est une start-up dont le siège est à Marseille et dont le but est de fournir toute une gamme de logiciels intelligents qui viendront guider le cardiologue pendant les interventions chirurgicales (de type ablation). La création de l’entreprise fait suite à la découverte d’une nouvelle procédure médicale pour traiter la fibrillation atriale (l’arythmie cardiaque la plus fréquente au monde) par les fondateurs de l’entreprise experts mondiaux en rythmologie interventionnelle et analyse des signaux intracardiaques.
Afin d’automatiser cette procédure complexe qui est le fruit de dizaines d’années de recherche, nous développons un logiciel d’intelligence artificielle. Nous nous sommes lancés dans cette belle aventure il y a quatre ans et amorçons une phase de croissance rapide, raison pour laquelle nous recrutons un développeur talentueux !
Missions
1) Conception et mise à jour des différentes versions du logiciel (développement, test et production).
2) Développement et implémentation de nouveaux modules R&D (développés par l’équipe Data Science).
Compétences recherchées
– TypeScript, React, Node, Python
– GIT
– Test unitaire (Jest)
– Documentation
– Using type systems
– Using refactorings
Nous recherchons un profil qui aime travailler en équipe:
– Code review
– Peer programming
– Humilité et bienveillance
Compétences additionnelles appréciées
– Docker
– Linux
– C++, Kotlin, Rust
Profil recherché
Passionné par la programmation avec la volonté d’en connaître toujours plus.
Facilité à s’intégrer dans une équipe Agile pluridisciplinaire avec des profils variés.
Dynamique, enthousiaste et volontaire avec un intérêt pour la médecine et les nouvelles technologies.
Comment nous travaillons :
– L’équipe fonctionne en processus agile : itérations, réunions quotidiennes, revues de code, tests automatisés et intégration continue.
– Notre activité est structurée autour d’un outil de gestion de tickets et de dépôts Git.
– Notre domaine impose une démarche qualité importante.
– Nous écrivons la plupart de notre code en TypeScript, Python et C++, et envisageons d’utiliser Kotlin et Rust pour de prochains développements.
Conditions et processus de recrutement
Poste en CDI statut cadre basé à Marseille 6ème. Vous souhaitez en savoir plus?
N’hésitez pas à envoyer votre CV sur: hr@volta-medical.com
Senior Clinical Research Scientist H/F
Marseille, France
Senior Clinical Research Scientist H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during electrophysiology procedures.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Missions
Volta is looking for an innovative clinical and scientific expert reporting directly to the VP of Clinical & Regulatory Affairs who will be responsible for:
– Developing the publication planning/strategy and supporting the dissemination of scientific/clinical data through strategically aligned scientific communications (manuscripts, abstracts, conference presentations) by providing scientific expertise and authoring support as required.
– Conducting and preparing literature reviews and clinical watch.
– Helping design clinical studies: define appropriate hypotheses, study rationale, measurable endpoints, and methods to ensure scientific integrity of the study in accordance with current regulations, guidelines and practices.
– Ensuring scientific integrity of clinical study data by assisting in the development of study plans, data collection, review, and analysis materials (e.g., CRFs, statistical analysis plans, TLFs).
– Providing support in the development of program documents, author and/or critically review regulatory and clinical documents, including clinical plans, pre-submission documents, clinical study protocols and reports, and responses to regulatory agencies or institutional review boards/ethics committees.
– Reviewing, analyzing and interpreting study data; prepare and present data summaries, reports.
– Contributing ideas for business proposals and new projects
– Collaborating with a variety of internal and external partners and stakeholders, such as clinical investigators, KOLs and biostatisticians, as well as multidisciplinary internal teams (Clinical, Medical, Regulatory, R&D, business development, commercial operations, legal, etc.)
Profile:
– PhD (preferred) or master’s degree in biomedical sciences,
– Minimum of 6 years related industry experience in Medical Device or Pharmaceuticals including analyzing, interpreting, and summarizing clinical data for internal and external audiences.
– Experience with feasibility and pivotal clinical studies
– Ability to interpret study results and perform data analyses
– Proficient knowledge of medical terminology
– Demonstrated understanding of human physiology and cardiac electrophysiology
– Working knowledge of statistics to apply and understand appropriate study design and data analysis of clinical trials, demonstrated experience using statistical software (e.g., R, Matlab, SAS)
– Expertise with GCP and regulatory compliance guidelines for clinical trials
– Must have excellent working knowledge of Word, Excel, PowerPoint, reference management systems
– Advanced scientific writing skills
– Fluent in English,
– Good level in French,
Soft skills
– Strong problem-solving aptitude
– Intellectual curiosity
– Good communication skills
– High attention to details
– Ability to manage multiple tasks and ensure adherence to timelines
– Ability to work effectively independently and with cross-functional teams
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Conditions and recruitment process
The position is on a full-time CDI, “cadre” status, 40% remote work possible.
Does this sound exciting to you? Then do not hesitate to apply! Please send your resume to hr@volta-medical.com
Product Owner H/F
Marseille, France
Product Owner H/F
Who we are?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and the US working in a great environment in order to make difference in the health market. Our main product is a therapeutic solution using the data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status, or any other characteristic protected by law.
Mission
Under the supervision of the Head of product, the Product Owner will be working together with the software engineering team to :
● Define user stories and their acceptance criteria
● Participate as the product owner in agile ceremonies and act as a liaison between the development team and the product team
● Contribute to product backlog management: ensure prioritized features are developed
● Gather requirements from stakeholders and define use cases
● Contribute to regulatory artifacts documentation (user, technical requirements)
● Work in close collaboration with test team to ensure requirements are covered
● Support product team with product validation
● Contribute to defining product roadmap and priorities working closely with the head of product
● Understand the competition landscape
● Help marketing team with marketing material
Profile
● Engineering degree (MSc) in biomedical or computer science,
● At least 2-3 years experience in a product owner, field technical engineer or application engineer role within the MedTech industry,
● Enjoys working with the software engineering team and fast learner,
● Proactive in finding creative solutions to challenging problems,
● Basic knowledge (or interest and willingness to learn) of web architecture, software development,
● Communicates effectively in written and oral English and French, with the ability to present and defend your ideas to stakeholders,
● Experience working with issues management tools such as Jira, and knowledge of software agile medothology is a plus,
● Knowledge of ISO 13485, IEC 62304, IEC 82304-1 is a plus.
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated, and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Condition and recruitment process
The position is on CDI, based in Marseille 6th (on the 17th Floor of a Tour Méditerranée).
Do you want to know more about our team?
We will evaluate your application soon as possible. Please send her your resume: hr@volta-medical.com
Senior Test Engineer (test Leader) H/F
Marseille, France
Senior Test Engineer (test Leader) H/F
Who are we ?
Volta Medical is an AI medtech startup. Volta has developed the first AI software to guide
physicians in atrial fibrillation (AF) treatment during a curative intervention called ablation. With 11 million patients in the EU alone (14-17 million in 2030) and 33 million patients worldwide, AF is the most common arrhythmia (irregular heart rhythm) in adults and ablation is currently one of the most advanced treatment options.
After 15+ years of research, Volta Medical has developed a product using a data-driven approach for optimal real-time identification of dispersion zones during atrial fibrillation ablation. This solution is built on artificial intelligence (AI, deep and machine learning) approaches to gain insight into innovative therapies for AF.
Volta is based in Marseille and has international presence in the USA. Our mission is to provide a range of intelligent and innovative softwares that will guide the cardiologist during surgical procedures in the operating room. We have recently raised our series A round and the team now consists of more than 30 collaborators with a branch in the United States. We embarked on this adventure more than four years ago and are entering another phase of rapid growth.
At Volta Medical we believe in maintaining high standards, agility and proactivity in our work. We have a multicultural team, embracing diversity and gender balance at the workplace.
Responsibilities
You will join a highly skilled technical team composed of data scientists and developers using the
Agile Method. In this context, you will:
➔ Create test strategies, test plans and test cases for on-going projects
➔ Contribute to test execution campaigns planning and execution, including smoke test and
regression testing, problem reporting (defect management),
➔ Set up test environments, test management software
➔ Ensure proper traceability and test coverage
➔ Monitor test execution, report the status through progress and quality metrics
Additionally, you will collaborate with the management team and technical leads on the following topics:
➔ Definition and improvement of test policies,
➔ Identification and planning of test resources
➔ Increased adoption of automated testing : identifying automation opportunities, setting up common practices, training, selecting tools and frameworks
Required Experience
– at least 5 years’ experience as a software test engineer, or 1 year as Test Leader, in a
regulated environment
Valued Experience
– Experience in the Medical Device industry
– Usability and cybersecurity testing,
– ISTQB,
– experience with agile development.
Soft skills
– Problem-solving aptitude
– Strong verbal and written communication skills
– Rigor, attention to details
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated and experienced team,
– Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th.
Does this sound exciting to you? Then do not hesitate to apply!
Send your resume: hr@volta-medical.com
Développeur – Concepteur Senior H/F
Marseille, France
Développeur – Concepteur Senior H/F
Qui sommes-nous ?
Volta Médical est une start-up dont le siège est à Marseille et dont le but est de fournir toute une gamme de logiciels intelligents qui viendront guider le cardiologue pendant les interventions chirurgicales (de type ablation). La création de l’entreprise fait suite à la découverte d’une nouvelle procédure médicale pour traiter la fibrillation atriale (l’arythmie cardiaque la plus fréquente au monde) par les fondateurs de l’entreprise experts mondiaux en rythmologie interventionnelle et analyse des signaux intracardiaques.
Afin d’automatiser cette procédure complexe qui est le fruit de dizaines d’années de recherche, nous développons un logiciel d’intelligence artificielle. Nous nous sommes lancés dans cette belle aventure il y a quatre ans et amorçons une phase de croissance rapide, raison pour laquelle nous recrutons un développeur senior talentueux !
Dans l’exercice de vos fonctions, vous devrez (entre autres):
– Concevoir et développer les différentes versions du logiciel.
– Développer et maintenir des briques logicielles d’acquisition de signal.
– Aider au développement et au portage d’algorithmes de Data Science.
Nous serons heureux de vous avoir dans notre équipe si vous :
– Aimez résoudre des problèmes complexes et ambitieux.
– Avez au moins 4 ans d’expérience professionnelle dans le développement logiciel.
– Avez une bonne expérience de la programmation système.
– Pouvez concevoir et écrire du code facile à lire et à maintenir.
– Avez un fort esprit d’équipe, êtes ouverts à des opinions divergentes, et pouvez argumenter votre point de vue avec un raisonnement solide.
– Etes capable d’échanger en anglais à l’écrit et à l’oral.
Nous serons particulièrement ravis si vous :
– Avez préalablement développé en C, C++ ou Rust.
– Avez des connaissances sur des langages de plus haut niveaux comme Python, Javascript et/ou TypeScript.
– Êtes familier avec le traitement de signal et/ou la Data Science.
Comment nous travaillons :
– L’équipe fonctionne en processus agile : itérations, réunions quotidiennes, revues de code, tests automatisés et intégration continue.
– Notre activité est structurée autour d’un outil de gestion de tickets et de dépôts Git.
– Notre domaine impose une démarche qualité importante.
– Nous écrivons la plupart de notre code en TypeScript, Python et C++, et envisageons d’utiliser Kotlin et Rust pour de prochains développements.
Conditions et processus de recrutement
Poste en CDI statut cadre basé à Marseille 6ème. Vous souhaitez en savoir plus?
N’hésitez pas à envoyer votre CV sur: hr@volta-medical.com
DevOps Engineer H/F
Marseille, France
DevOps Engineer H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 40 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Responsibilities
You will join a highly skilled technical team composed of data scientists and developers working with the Agile Methodology.
In the context of a significant growth of the R&D team, your main mission will be to build, deploy and maintain a state of the art Continuous Integration framework which can serve the needs of all current and future projects (products, data collection tools, data science modules) : automated build and deployment, automated unit and functional testing, automated and comprehensive dashboards.
You will
– Assess existing CI/CD tools, propose, and implement improvements,
– Watch DevOps trends, suggest new tools and practices, implement, and deploy them
– Support the R&D team in the use of the platform,
– Develop key automated tests,
– Promote automated test adoption in the teams through use of common practices and tools.
Required Experience
– Good knowledge of DevOps culture and experience in DevOps operations
– Experience in Linux system administration, wired and wireless networks
– Containers and virtual machines: Docker, Swarm
– Experience in managing the security of sensible databases with appropriate tools
Valued Experience
– Machine Learning context
– GitLab
– AWS
– Vault
– ELK/EFK
– K8S
Soft skills
– Problem-solving aptitude
– Knowledge of technological trends and threats
– Good communication skills
– Attention to details
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th.
Does this sound exciting to you ? Then do not hesitate to apply!
Loren Siry will assess your application as soon as possible.
Do not hesitate to send her your resume/CV: hr@volta-medical.com
Signal Processing Engineer H/F
Marseille, France
Signal Processing Engineer H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 35 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
At Volta Medical we believe in maintaining high standards, agility and proactivity in our work. We have an enthusiastic multicultural team, embracing diversity and gender balance at the workplace.
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination. We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Job brief
We are looking for a Signal Processing Engineer to be a part of our R&D team. Solid technical background and interest in AI for health applications are essential in this role.
You will be part of a technical team of around 12 people (8 Developers and 4 Data Scientists). In this context, you will:
➔ Build state of the art machine learning algorithms to be used in the operation room (EP Lab),
➔ Participate in the effort to develop better data collecting tools suited to the constraints of the health domain.
➔ Participate in the production of necessary regulatory documents for the clearance / approval of the developed softwares.
➔ Produce code of high quality (coding guidelines, unit tests, etc.),
➔ Participate in scientific congresses.
Required Profile
– Graduate from a master’s / engineering school (BAC + 5), in mathematics, physics, data science or statistics,
– At least 1 year of experience in Machine Learning R&D projects Managerial, strategic and soft skills
– Problem-solving aptitude
– Ability to conduct technological analyses and research
– Excellent communication skills
– Excellent organizational and time-management skills
– Attention to details.
– Interested in the recent developments of AI / ML research
Technical experience
– Very good academic level in machine learning (mathematical and algorithmic background, good practices in ML, Deep learning, Classical machine learning algorithms, Signal processing, etc …)
– Computer Science (Complexity calculation, parallel programming)
– Python (PyTorch, Tensorboard, Pandas, numpy, asyncio, Pytest, scikit-learn, XGBoost, etc…)
– GIT
– Docker
– Database
– Linux
– Very good level in English
These technologies are not required but would be appreciated:
– PostgreSQL
– Advanced knowledge in computer science (Dynamic programming, socket communication protocols, etc …)
– Code optimization in python (Numba / Cython)
– Lower level computer language knowledge (C, Assembly, etc…)
– Have participated in the publication of a scientific article
Why should you join?
AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
You will get an opportunity to work with a highly diverse, motivated and experienced team,
Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th. Do you want to apply and know more about our team: hr@volta-medical.com
Field Technical Engineer H/F
Marseille, France
Field Technical Engineer H/F
Who we are?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 35 employees! We raised a $27 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination.
We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Mission
Under the supervision of the Head of Sales, the Field Technical Engineer will be responsible for:
● Deploy and install our solutions at hospitals,
● Oversee application support during operations with surgeons (especially during the deployment of our clinical studies),
● Train doctors and teams on-site to use our solutions,
● Be the first point of contact with our customers,
● Play a central role in customer relations and loyalty. You are the ambassador of our products.
Profile
● Engineering degree (Msc) in biomedical,
● First experience (at least an internship) in a similar role,
● English written and spoken.
Why should you join?
– AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
– You will get an opportunity to work with a highly diverse, motivated, and experienced team,
Condition and recruitment process
The position is on CDI, fully remote with frequent travel through France, Germany, Belgium, and Netherlands.
Do you want to know more about our team? So, let’s apply!
We will evaluate your application soon as possible. Please send her your resume: hr@volta-medical.com
Senior Data Scientist H/F
Marseille, France
Senior Data Scientist H/F
Who are we ?
Volta Medical is a young innovative start-up in the south of France, aimed at creating and bringing to the market AI software products to help cardiologists during heart surgeries.
We are a team of HEC and Ecole Polytechnique graduates, as well as world-known cardiologists from France and US working in a great environment in order to make difference on the health market. Our main product is a therapeutic solution using data-driven approach for treating AF based on intracardiac signals’ analysis. This solution builds on artificial intelligence approaches to gain insight into innovative therapies for AF.
In fact, this represents one of the first fully AI-guided successful surgical procedures, serving as a revolutionary step in the field of AI.
We have started this adventure for 4 years and now we are 35 employees! We raised a $31 M Series A round in November 2020 led by Gilde Healthcare (Largest Healthcare VC in Europe).
At Volta Medical we believe in maintaining high standards, agility and proactivity in our work. We have an enthusiastic multicultural team, embracing diversity and gender balance at the workplace.
Volta Medical is an equal opportunity employer that strictly prohibits unlawful discrimination. We recruit, employ, train, compensate, and promote without regard to an individual’s race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, mental/physical disability, medical condition, marital status or any other characteristic protected by law.
Job brief
We are looking for a Senior Data Scientist to be a part of our R&D team. Strong technical background and experience in AI for health applications are essential in this role.
Responsibilities
You will be part of a technical team of around 12 people (8 Developers and 4 Data Scientists). In this context, you will:
➔ Formulate, suggest and manage data driven projects according to business priorities
➔ Communicate technology strategy to partners and investors
➔ Build state of the art machine learning algorithms to be used in the operating room (EP Lab)
➔ Contribute to the development of data collecting tools suited to the constraints of
the health domain.
➔ Produce regulatory documents required for the clearance /
approval of the developed algorithms.
➔ Produce code of high quality (coding guidelines, unit tests, etc.)
➔ Participate in scientific congresses
Required Profile
– Graduate from a master’s / engineering school (BAC + 5), in mathematics, physics, data
science or statistics,
– 5-10 years of experience in Machine Learning R&D projects
Managerial, strategic and soft skills
– Problem-solving aptitude
– Ability to conduct technological analyses and research
– Team player attitude
– Supervision and mentoring skills
– Excellent communication skills
– Excellent organizational and time-management skills
Technical experience
– Aware of recent developments of AI / ML research
– Excellent academic level in machine learning (mathematical and algorithmic background,
good practices in ML, Deep learning, Classical machine learning algorithms, Signal processing, etc …)
– Good background in SW Engineering practices, Agile methodology
– Python (PyTorch, Tensorboard, Pandas, numpy, asyncio, Pytest, scikit-learn, XGBoost, etc…)
– GIT, Docker, Linux
– Very good level in English
These skills are not required but would be appreciated:
– PostgreSQL
– Advanced knowledge in computer science (sockets, multi-threading, GPU, etc …)
– Code optimization in python (Numba / Cython)
– Lower level computer language knowledge (C, Assembly, etc…)
– Experience in scientific publications & patents
Why should you join?
AI is supposed to revolutionize healthcare in the coming years and we are at the forefront of this revolution. You will get an opportunity to understand the systemic challenges and the areas of impact that AI can have in healthcare,
You will get an opportunity to work with a highly diverse, motivated and experienced team,
Opportunity to experience the Mediterranean lifestyle. It is great if you enjoy nature and the ocean!
Recruitment process
The position is on a full-time CDI, “cadre” status, based in Marseille 6th. Do you want to apply and know more about our team?
Send your CV to hr@volta-medical.com If your CV is accepted, our HR will contact you for a first phone conversation.
Candidates who will unfortunately not be selected will receive an email.
Science
ABOUT Atrial Fibrillation
The heart beats are generated by the sino-atrial node, a small tissue region in the right atrium. The propagation of impulses to both upper chambers of the heart – i.e the two atria – causes them to contract and move the blood to the lower chambers of the heart, a.k.a the ventricles.
Atrial fibrillation (AF) is the most common heart rhythm disturbance in adults. AF is caused by abnormal electrical impulses forming anywhere in the atria. AF may be recorded on an electrocardiogram (ECG). The beating heart of AF patients is fast and irregular.
Physicians classify AF according to the duration of arrhythmia episodes. Brief episodes correspond to paroxysmal AF. Longer episodes are known as persistent AF.
ABOUT Interventional electrophysiology
Interventional electrophysiology is a surgical specialty. It requires multiple years of experience and consists of conducting intra-cardiac procedures to cure cardiac arrhythmias such as atrial fibrillation.
During an intervention, an electrophysiologist is required to analyze a large amount of information in real-time. First, an accurate visual analysis of up to 30 electrograms is essential. Then, non-electrogram information coming from multiple sources needs additional consideration.
All data allow for seamless progress through the multiple-step procedural workflow.
